Crinetics Pharmaceuticals, Inc. (CRNX)
38.23
-0.67
(-1.72%)
USD |
NASDAQ |
Mar 06, 16:00
38.27
+0.04
(+0.10%)
After-Hours: 20:00
Crinetics Pharmaceuticals Cash from Investing (Quarterly) : 57.11M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Plus Therapeutics, Inc. | 1.297M |
| Madrigal Pharmaceuticals, Inc. | 27.58M |
| GT Biopharma, Inc. | 0.00 |
| Axsome Therapeutics, Inc. | -0.071M |
| Sutro Biopharma, Inc. | 39.99M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -92.90M |
| Cash from Financing (Quarterly) | 26.04M |
| Free Cash Flow | -383.68M |
| Free Cash Flow Per Share (Quarterly) | -0.9817 |
| Free Cash Flow to Equity (Quarterly) | -92.76M |
| Free Cash Flow to Firm (Quarterly) | -93.36M |
| Free Cash Flow Yield | -10.67% |